DE69231608T2 - Verfahren und mittel für die analyse von genetischem polymorphismus des angiotensin-umwandlungs-enzyms i - Google Patents

Verfahren und mittel für die analyse von genetischem polymorphismus des angiotensin-umwandlungs-enzyms i

Info

Publication number
DE69231608T2
DE69231608T2 DE69231608T DE69231608T DE69231608T2 DE 69231608 T2 DE69231608 T2 DE 69231608T2 DE 69231608 T DE69231608 T DE 69231608T DE 69231608 T DE69231608 T DE 69231608T DE 69231608 T2 DE69231608 T2 DE 69231608T2
Authority
DE
Germany
Prior art keywords
pct
genetic polymorphism
conversion enzyme
analyzing genetic
angiotensin conversion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69231608T
Other languages
English (en)
Other versions
DE69231608D1 (de
Inventor
Florent Soubrier
Christine Hubert
Pierre Corvol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of DE69231608D1 publication Critical patent/DE69231608D1/de
Application granted granted Critical
Publication of DE69231608T2 publication Critical patent/DE69231608T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
DE69231608T 1991-06-27 1992-06-24 Verfahren und mittel für die analyse von genetischem polymorphismus des angiotensin-umwandlungs-enzyms i Expired - Fee Related DE69231608T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9108020A FR2678285A1 (fr) 1991-06-27 1991-06-27 Moyens et procedes pour l'etude du polymorphisme genetique de l'enzyme de conversion de l'angiotensine 1.
PCT/FR1992/000574 WO1993000360A1 (fr) 1991-06-27 1992-06-24 Moyens et procedes pour l'etude du polymorphisme genetique de l'enzyme de conversion de l'angiotensine i

Publications (2)

Publication Number Publication Date
DE69231608D1 DE69231608D1 (de) 2001-01-25
DE69231608T2 true DE69231608T2 (de) 2001-06-13

Family

ID=9414424

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231608T Expired - Fee Related DE69231608T2 (de) 1991-06-27 1992-06-24 Verfahren und mittel für die analyse von genetischem polymorphismus des angiotensin-umwandlungs-enzyms i

Country Status (8)

Country Link
US (1) US5736323A (de)
EP (1) EP0591332B1 (de)
JP (1) JPH06508524A (de)
AT (1) ATE198219T1 (de)
CA (1) CA2111953A1 (de)
DE (1) DE69231608T2 (de)
FR (1) FR2678285A1 (de)
WO (1) WO1993000360A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723590B1 (fr) * 1994-08-09 1996-10-25 Inst Nat Sante Rech Med Procede de detection et trousse de diagnostic in vitro d'une predisposition a l'infarctus du myocarde
US6197505B1 (en) * 1997-04-04 2001-03-06 Pyrosequencing Ab Methods for assessing cardiovascular status and compositions for use thereof
US6194556B1 (en) * 1997-12-11 2001-02-27 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor
US6610497B1 (en) * 1997-12-11 2003-08-26 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
AU4518399A (en) * 1998-06-30 2000-01-17 University Of Wales College Of Medicine Alzheimer's disease
US7514213B2 (en) * 2002-11-15 2009-04-07 Quest Diagnostics Investments Incorporated Compositions and methods for determining genotypes
US7794933B1 (en) 2005-01-04 2010-09-14 Myriad Genetics, Inc. Depression-related gene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636968B1 (fr) * 1988-09-27 1992-01-03 Inst Nat Sante Rech Med Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) humaine, et ses applications, notamment pour le diagnostic in vitro de l'hypertension arterielle
FR2649412B1 (fr) * 1989-07-05 1995-10-20 Inst Nat Sante Rech Med Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) testiculaire humaine, et ses applications, notamment pour le depistage in vitro de cette enzyme dans l'organisme

Also Published As

Publication number Publication date
FR2678285A1 (fr) 1992-12-31
DE69231608D1 (de) 2001-01-25
JPH06508524A (ja) 1994-09-29
ATE198219T1 (de) 2001-01-15
US5736323A (en) 1998-04-07
WO1993000360A1 (fr) 1993-01-07
FR2678285B1 (de) 1994-08-19
EP0591332A1 (de) 1994-04-13
CA2111953A1 (fr) 1993-01-07
EP0591332B1 (de) 2000-12-20

Similar Documents

Publication Publication Date Title
ATE483822T1 (de) Primer für nukleinsäureamplifikation in pcr- basierten klonalitätsstudien
DE3853678T2 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
ATE231187T1 (de) Methoden zur detektion von mikrometastasen bei prostata-krebs
DE69729122D1 (de) KüNSTLICHE FEHLHYBRIDISIERUNG
NO940744L (de)
ES2110604T3 (es) Metodo de secuenciacion de adn.
DE69942444D1 (de) Bestimmung des genotyps eines amplifikationsproduktes an mehreren allelen stellen
DE69636895D1 (de) Die Verwendung der 3'-wesentlichen Bearbeitungswirksamkeit von DNS-Polymerase
ATE190357T1 (de) Schnelles verfahren fur die dns sequenzierung und diagnostische anwendungen
DE69009774D1 (de) Verfahren zum klonieren und reagenziensatz.
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
DE69231608T2 (de) Verfahren und mittel für die analyse von genetischem polymorphismus des angiotensin-umwandlungs-enzyms i
DE69823372T8 (de) Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen
FR2774097B1 (fr) Utilisation de derives d'indolamine dans la detection d'une activite de peptidase ou dans la detection de micro-organismes
ES2123000T3 (es) Secuencias de adn del papilomavirus hpv 42 y su aplicacion en diagnostico.
DE69709804T2 (de) Nachweis von nukleotidsequenzen durch signalamplifizierung
DE69604051D1 (de) Verfahren zum sensitiven nachweis von reverser transcriptase
ATE292191T1 (de) Primer und sonden zur amplifizierung, erkennung und typisierung von mycoplasma pneumoniae
DE69506704D1 (de) Verfahren und proben zum nachweis von mit dem locus der infantilen spinalamyotrophien verbundenen markern
DE69636917D1 (de) Nucleinsäuresonden und Amplifizierungsoligonukleotide für Neisseria Spezies
DE50111824D1 (de) Diagnose von mit humos assoziierten krankheiten
ATE317455T1 (de) Nachweis und quantifizierung von microorganismen anhand amplifizierung und restriktionsenzymeanalyse
FI973762A0 (fi) Ny gen
ATE407145T1 (de) Analyse und verwendung von par 1 polymorphismen zur risikoabschätzung für kardiovaskuläre erkrankungen
ES2115553A1 (es) Metodo para detectar la presencia de polimorfismos de dna, estuche de ensayo y acidos nucleicos recombinantes correspondientes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee